5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 5.44▼ | 5.44▼ | 5.46▼ | 5.46▼ | 5.44▼ |
MA10 | 5.46▼ | 5.47▼ | 5.47▼ | 5.46▼ | 5.25▲ |
MA20 | 5.43▼ | 5.46▼ | 5.43▼ | 5.37▲ | 5.17▲ |
MA50 | 5.35▲ | 5.30▲ | 5.21▲ | 5.16▲ | 4.47▲ |
MA100 | 5.17▲ | 5.14▲ | 5.14▲ | 5.11▲ | 4.78▲ |
MA200 | 5.08▲ | 4.87▲ | 4.70▲ | 4.43▲ | 6.34▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.010▼ | -0.016▼ | -0.013▼ | -0.006▼ | 0.012▲ |
RSI | 49.666▼ | 51.351▲ | 52.771▲ | 54.889▲ | 60.611▲ |
STOCH | 27.037 | 41.926 | 64.815 | 69.173 | 75.960 |
WILL %R | -37.778 | -37.778 | -37.778 | -23.636▲ | -20.833▲ |
CCI | -171.847▼ | -148.669▼ | -103.058▼ | -97.126 | 95.925 |
Friday, April 11, 2025 02:35 PM
PORTLAND, Maine, April 08, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and ...
|
Friday, April 11, 2025 02:35 PM
PORTLAND, Maine, April 08, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and ...
|
Tuesday, April 08, 2025 09:05 AM
ImmuCell Corporation PORTLAND, Maine, April 08, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 5.28 | 5.42 | 5.28 | 5.42 | 15,701 |
30/04/25 | 5.39 | 5.49 | 5.3631 | 5.42 | 3,157 |
29/04/25 | 5.50 | 5.50 | 5.43 | 5.435 | 23,563 |
28/04/25 | 5.51 | 5.5372 | 5.4363 | 5.50 | 14,357 |
25/04/25 | 5.42 | 5.5416 | 5.42 | 5.50 | 7,337 |
24/04/25 | 5.44 | 5.55 | 5.37 | 5.50 | 16,770 |
23/04/25 | 5.4716 | 5.5499 | 5.39 | 5.50 | 6,002 |
22/04/25 | 5.35 | 5.55 | 5.35 | 5.46 | 18,338 |
21/04/25 | 5.35 | 5.54 | 5.35 | 5.38 | 5,187 |
17/04/25 | 5.55 | 5.55 | 5.3833 | 5.50 | 4,087 |
|
|
||||
|
|
||||
|
|